{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:06:00Z","timestamp":1790697960310,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.ijantimicag.2010.07.002","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T08:39:31Z","timestamp":1282466371000},"page":"408-414","source":"Crossref","is-referenced-by-count":74,"title":["Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia\u2013Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)"],"prefix":"10.1016","volume":"36","author":[{"given":"Po-Ren","family":"Hsueh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Badal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Hawser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl J.","family":"Hoban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel K.","family":"Bouchillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1345\/aph.1L473","article-title":"Comparison of 2002\u20132006 OPTAMA programs for US hospitals: focus on Gram-negative resistance","volume":"43","author":"Crandon","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ijantimicag.2004.08.008","article-title":"\u03b2-Lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates","volume":"24","author":"Nijssen","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jinf.2009.06.003","article-title":"Increasing extended-spectrum \u03b2-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia\/Pacific region: data from the SMART study 2002\u20132006","volume":"59","author":"Ko","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/sur.2005.6.439","article-title":"In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"6","author":"Chow","year":"2005","journal-title":"Surg Infect"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0025","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jac\/dki117","article-title":"In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"55","author":"Paterson","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jac\/dkl199","article-title":"In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)","volume":"58","author":"Rossi","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijantimicag.2006.04.010","article-title":"In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia\u2013Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)","volume":"28","author":"Hsueh","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0040","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1128\/AAC.00426-09","article-title":"Emergence of high levels of extended-spectrum \u03b2-lactamase-producing Gram-negative bacilli in Asia\/Pacific: data from SMART 2007","volume":"53","author":"Hawser","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0045","unstructured":"Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI; 2009."},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0050","unstructured":"Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI; 2010."},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0055","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2008-06-27 (version 1.2). http:\/\/www.eucast.org [accessed 20 May 2010]."},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0060","unstructured":"Clinical and Laboratory Standard Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 7th ed. Document M07-A7. Wayne, PA: CLSI; 2006."},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0065","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/AAC.01228-08","article-title":"Prevalence and risk factors for selection of quinolone-resistant Escherichia coli strains in fecal flora of patients receiving quinolone therapy","volume":"53","author":"Yagci","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1086\/592703","article-title":"Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance","volume":"30","author":"Lautenbach","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0075","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ajic.2007.05.008","article-title":"Clinical and molecular epidemiology of community-onset, extended-spectrum \u03b2-lactamase-producing Escherichia coli infections in Thailand: a case\u2013case\u2013control study","volume":"35","author":"Apisarnthanarak","year":"2007","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/649537","article-title":"Community-onset bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli: risk factors and prognosis","volume":"50","author":"Rodr\u00edguez-Ba\u00f1o","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0085","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00774-09","article-title":"Characterization of a new metallo-\u03b2-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India","volume":"53","author":"Yong","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0090","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1086\/507274","article-title":"Imipenem resistance among Pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes","volume":"27","author":"Lautenbach","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0095","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1128\/AAC.00464-08","article-title":"Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation","volume":"52","author":"Tanimoto","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0105","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1086\/378702","article-title":"Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections","volume":"37","author":"Solomkin","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijantimicag.2007.03.002","article-title":"Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia","volume":"30","author":"Hsueh","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0115","first-page":"317","article-title":"In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center in Taiwan: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2002\u20132006","volume":"42","author":"Chen","year":"2009","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.diagmicrobio.2006.03.019","article-title":"Use of cefepime for the treatment of infections caused by extended spectrum \u03b2-lactamase-producing Klebsiella pneumoniae and Escherichia coli","volume":"56","author":"Labombardi","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0125","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1128\/AAC.47.11.3442-3447.2003","article-title":"Cefepime versus imipenem\u2013cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study","volume":"47","author":"Zanetti","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.diagmicrobio.2005.09.011","article-title":"Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program","volume":"54","author":"Bhavnani","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0135","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s15010-009-7108-9","article-title":"A long journey from minimum inhibitory concentration testing to clinically predictive breakpoints: deterministic and probabilistic approaches in deriving breakpoints","volume":"37","author":"Dalhoff","year":"2009","journal-title":"Infection"},{"issue":"Suppl 6","key":"10.1016\/j.ijantimicag.2010.07.002_bib0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1469-0691.2005.01265.x","article-title":"Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations","volume":"11","author":"Andes","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0145","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1128\/AAC.47.5.1643-1646.2003","article-title":"Pharmacokinetics\u2013pharmacodynamics of cefepime and piperacillin\u2013tazobactam against Escherichia coli and Klebsiella pneumoniae strains producing extended-spectrum \u03b2-lactamases: report from the ARREST Program","volume":"47","author":"Ambrose","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.07.002_bib0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1592\/phco.2006.26.1.129","article-title":"Monte-Carlo simulation in the evaluation of susceptibility breakpoints: predicting the future: insights from the Society of Infectious Diseases Pharmacists","volume":"26","author":"Ambrose","year":"2006","journal-title":"Pharmacotherapy"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910003286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910003286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:49:59Z","timestamp":1559454599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857910003286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0924857910003286"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.07.002","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}